Monoferric for Prenatal Iron Deficiency

Part of paid clinical trials in Portland, Oregon.

Sponsor
Oregon Health and Science University
Study ID
NCT05763043
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Obstetric Labor Complications

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Ferric derisomaltose — DRUG
    Participants between the gestational ages of 14 to 42 weeks with iron deficiency will receive IV Ferric derisomaltose at a routine prenatal visit.

Study Details

A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.

Key Dates

Start date
Jan 18, 2024
Status verified
Sep 2024
Primary completion
Oct 31, 2028
Completion
Oct 31, 2028

Study Design

Enrollment
80 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Ferric derisomaltose

Primary Outcome Measure

The proportion of participants who experienced a resolution of iron deficiency anemia [ Time Frame: From enrollment to 6 weeks post partum ]

Central Contacts

  • Women's Health Research Unit Research Unit Department of OB/Gyn
    503-494-3666
    [email protected]

Locations (1)

FacilityCityStateZIPSite coordinators
Oregon Health & Science UniverityPortlandOregon97239
Women's Health Research Unit
[email protected]
503-494-3666

Find similar trials in Portland, OR

By research site
Oregon Health & Science Univerity· Portland, OR

Related Studies